跳至主要内容
临床试验/CTRI/2021/11/037727
CTRI/2021/11/037727尚未招募2 期

Efficacy of Majoon Chobchini versus Majoon Ushba with Roghane Surkh in Post Chikungunya Arthritis ââ?¬â?? A Randomized Single Blind Comparative Clinical Trial

Rajiv Gandhi University of Health Sciences Karnataka Bangalore0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with P/H/O Chikungunya fever 03
  • Patients with DAS 28 >3.2 and CDAI >
  • Patients who will give consent and able to
  • do follow up

排除标准

  • Patients below 18 and above 50 years
  • Patients with DAS 28 < 3.2 and CDAI < 10
  • Patients having arthritis other than Post
  • Chikungunya fever
  • Patients suffering from autoimmune
  • diseases or systemic illness like
  • Hypertension, DM, Malignancy, Liver or
  • Kidney dysfunction
  • Patients had received systematically
  • administered or intra-articular
  • corticosteroids, Hydroxychloroquine,
  • Sulfasalazine, methotrexate, NSAIDs or
  • CAM therapy within 02 weeks prior to
  • Pregnant and lactating women

研究者

发起方
Rajiv Gandhi University of Health Sciences Karnataka Bangalore

相似试验